Antimony toxicity: Difference between revisions
ClaireLewis (talk | contribs) No edit summary |
|||
(3 intermediate revisions by one other user not shown) | |||
Line 1: | Line 1: | ||
==Background== | ==Background== | ||
*Antimony is a metalloid and will react as a metal and nonmetal | *Antimony is a metalloid and will react as a metal and nonmetal | ||
**Shares many similar properties with arsenic | **Shares many similar properties with [[arsenic]] | ||
*Used to treat leishmaniasis and schistosomiasis | *Used to treat [[leishmaniasis]] and [[schistosomiasis]] | ||
**Most reported cases are due to complication of treatment | **Most reported cases are due to complication of treatment | ||
*Most common forms used for treatment are trivalent and pentavalent compounds | *Most common forms used for treatment are trivalent and pentavalent compounds | ||
Line 36: | Line 36: | ||
*'''GI''' | *'''GI''' | ||
**Anorexia | **Anorexia | ||
**Nausea/vomiting | **[[Nausea/vomiting]] | ||
***Leading to profound volume depletion | ***Leading to profound [[hypovolemia|volume depletion]] | ||
**Abdominal pain | **[[Abdominal pain]] | ||
**Diarrhea | **[[Diarrhea]] | ||
**Hemorrhagic gastritis | **Hemorrhagic [[gastritis]] | ||
**Pancreatitis | **[[Pancreatitis]] | ||
**Can react with water in salvia, producing sufficient hydrochloric acid to cause GI burns | **Can react with water in salvia, producing sufficient hydrochloric acid to cause GI [[burns]] | ||
*'''CV''' | *'''CV''' | ||
**Decreases myocardial contraction | **Decreases myocardial contraction | ||
**Decreased systolic pressure through decreased coronary vasomotor tone | **[[hypotension|Decreased systolic pressure]] through decreased coronary vasomotor tone | ||
**Bradycardia | **[[Bradycardia]] | ||
**EKG changes | **EKG changes | ||
***More common in pentavalent preparations | ***More common in pentavalent preparations | ||
***Prolonged QT | ***[[Prolonged QT]] | ||
***Inversion or flattening of T waves | ***Inversion or flattening of T waves | ||
***Torsades de pointes | ***[[Torsades de pointes]] | ||
*'''Pulmonary''' | *'''Pulmonary''' | ||
**Local irritation | **Local irritation | ||
***Laryngitis and Tracheitis | ***[[Laryngitis]] and Tracheitis | ||
**Antimony pneumoconiosis | **Antimony [[pneumoconiosis]] | ||
***Chronic exposure | ***Chronic exposure | ||
***Cough, wheezing, and exertional dyspnea | ***[[Cough]], [[wheezing]], and exertional [[dyspnea]] | ||
***CXR showing diffuse, dense, punctate non-confluent opacities in the middle and lower lobes | ***[[CXR]] showing diffuse, dense, punctate non-confluent opacities in the middle and lower lobes | ||
*'''Renal''' | *'''Renal''' | ||
**Proteinuria | **[[Proteinuria]] | ||
**Increased BUN | **Increased BUN | ||
**ATN | **ATN | ||
**Renal failure | **[[Renal failure]] | ||
*'''Hepatic''' | *'''Hepatic''' | ||
**Elevated aminotransferase | **Elevated aminotransferase | ||
**Hepatic necrosis | **Hepatic necrosis | ||
*'''Hematologic''' | *'''Hematologic''' | ||
**Thrombocytopenia | **[[Thrombocytopenia]] | ||
**Leukopenia | **[[Leukopenia]] | ||
**Severe anemia seen in HIV patients being treated for leishmaniasis | **Severe [[anemia]] seen in HIV patients being treated for leishmaniasis | ||
*'''Dermatologic''' | *'''Dermatologic''' | ||
**Antimony Spots | **Antimony Spots | ||
***Papules and pustules around sweat glands | ***Papules and pustules around sweat glands | ||
***Can resemble varicella | ***Can resemble varicella | ||
**Eczema | **[[Eczema]] | ||
**Lichenification | **Lichenification | ||
*'''Musculoskeletal''' | *'''Musculoskeletal''' | ||
** | **[[Myalgia]]s | ||
** | **[[Arthralgia]]s | ||
*'''Reproductive''' | *'''Reproductive''' | ||
**Increased risk of spontaneous abortion and premature labor | **Increased risk of [[spontaneous abortion]] and [[premature labor]] | ||
*'''Ocular''' | *'''Ocular''' | ||
**Local irritation | **Local irritation | ||
**Conjunctivitis | **[[Conjunctivitis]] | ||
**Photophobia | **Photophobia | ||
**Corneal burn | **Corneal burn | ||
==Differential Diagnosis== | ==Differential Diagnosis== | ||
{{Heavy metals list}} | |||
==Evaluation== | ==Evaluation== | ||
*BMP | *BMP | ||
*CBC | *CBC | ||
* | *[[Urinalysis]] | ||
*EKG to look for cardiac affects of antimony | *[[EKG]] to look for cardiac affects of antimony | ||
*Cardiac monitor to assess for arrhythmia | *Cardiac monitor to assess for arrhythmia | ||
*CXR | *[[CXR]] | ||
*Cases of stibine | *Cases of stibine | ||
**Add type and cross, and coagulation factors as transfusions are likely required | **Add type and cross, and coagulation factors as transfusions are likely required | ||
Line 127: | Line 104: | ||
==Management== | ==Management== | ||
*Consult Toxicology or [[poison control]] | |||
*Decontamination | *Decontamination | ||
**Gastric lavage may be of benefit | **[[Gastric lavage]] may be of benefit | ||
**Activated charcoal | **[[Activated charcoal]] | ||
***Additionally may use multi-dose activated charcoal due to enterohepatic circulation | ***Additionally may use multi-dose activated charcoal due to enterohepatic circulation | ||
**Dermal exposure | **Dermal exposure | ||
***Irrigation with soap and water | ***Irrigation with soap and water | ||
*Supportive Care | *Supportive Care | ||
**Fluid resuscitation | **[[Fluid resuscitation]] | ||
**Electrolyte repletion | **[[Electrolyte repletion]] | ||
**Monitor I/Os | **Monitor I/Os | ||
**Antiemetics | **[[Antiemetics]] | ||
**Blood transfusions based on institutional criteria | **[[pRBCs|Blood transfusions]] based on institutional criteria | ||
*Chelation | *Chelation | ||
**Dimercaprol | **[[Dimercaprol]] | ||
***200-600mg/d IM shown in a case series to increase urinary excretion of antimony<sub>1</sub> | ***200-600mg/d IM shown in a case series to increase urinary excretion of antimony<sub>1</sub> | ||
**Succimer | **[[Succimer]] | ||
**Dimercaptopropane-sulfonic acid (DMPS) | **Dimercaptopropane-sulfonic acid (DMPS) | ||
**All have shown improved survival in animal models | **All have shown improved survival in animal models | ||
===Stibine=== | ===Stibine=== | ||
*Place on high flow oxygen | *Place on high flow [[oxygen]] | ||
*Consider need for exchange transfusion to remove stibine-hemoglobin complexes | *Consider need for [[exchange transfusion]] to remove stibine-hemoglobin complexes | ||
==Disposition== | ==Disposition== | ||
* Will require admission to a monitored bed, likely ICU. | * Will require admission to a monitored bed, likely ICU. | ||
==References== | ==References== |
Revision as of 17:57, 16 October 2019
Background
- Antimony is a metalloid and will react as a metal and nonmetal
- Shares many similar properties with arsenic
- Used to treat leishmaniasis and schistosomiasis
- Most reported cases are due to complication of treatment
- Most common forms used for treatment are trivalent and pentavalent compounds
- Additional exposure occur from industrial exposures as inhalation of antimony dusts or fumes during processing
- Antimony is thought to exert its toxic effects due to inactivation of various thiol-containing proteins and enzymes
Stibine
- Most toxic form of antimony
- Colorless gas that is formed when antimony reacts with hydrogen
- Can result when mixing drain cleaners containing sodium hydroxide in areas with antimony ore
- Can result in massive hemolysis
Toxicokinetics
- Absorption
- Inhalation
- Ingestion
- Transcutaneous
- Bioavailability is 15-50%
- Distribution
- Predominately in highly vascular organs
- Trivalent form seen in red blood cells
- Pentavalent form accumulates in the liver
- Metabolism
- Pentavalent form is converted to trivalent form in the liver
- Excretion
- Trivalent form undergoes enterohepatic recirculation
- Renal
- Trivalent has a slow elimination with approximately 10% cleared within the first 24 hours
- Pentavalent will have approximately 50-60% cleared within the first 24 hours
Clinical Features
Clinical features can range from mild local irritation to organ dysfunction
- GI
- Anorexia
- Nausea/vomiting
- Leading to profound volume depletion
- Abdominal pain
- Diarrhea
- Hemorrhagic gastritis
- Pancreatitis
- Can react with water in salvia, producing sufficient hydrochloric acid to cause GI burns
- CV
- Decreases myocardial contraction
- Decreased systolic pressure through decreased coronary vasomotor tone
- Bradycardia
- EKG changes
- More common in pentavalent preparations
- Prolonged QT
- Inversion or flattening of T waves
- Torsades de pointes
- Pulmonary
- Local irritation
- Laryngitis and Tracheitis
- Antimony pneumoconiosis
- Local irritation
- Renal
- Proteinuria
- Increased BUN
- ATN
- Renal failure
- Hepatic
- Elevated aminotransferase
- Hepatic necrosis
- Hematologic
- Thrombocytopenia
- Leukopenia
- Severe anemia seen in HIV patients being treated for leishmaniasis
- Dermatologic
- Antimony Spots
- Papules and pustules around sweat glands
- Can resemble varicella
- Eczema
- Lichenification
- Antimony Spots
- Musculoskeletal
- Reproductive
- Increased risk of spontaneous abortion and premature labor
- Ocular
- Local irritation
- Conjunctivitis
- Photophobia
- Corneal burn
Differential Diagnosis
Heavy metal toxicity
- Aluminum toxicity
- Antimony toxicity
- Arsenic toxicity
- Barium toxicity
- Bismuth toxicity
- Cadmium toxicity
- Chromium toxicity
- Cobalt toxicity
- Copper toxicity
- Gold toxicity
- Iron toxicity
- Lead toxicity
- Lithium toxicity
- Manganese toxicity
- Mercury toxicity
- Nickel toxicity
- Phosphorus toxicity
- Platinum toxicity
- Selenium toxicity
- Silver toxicity
- Thallium toxicity
- Tin toxicity
- Zinc toxicity
Evaluation
- BMP
- CBC
- Urinalysis
- EKG to look for cardiac affects of antimony
- Cardiac monitor to assess for arrhythmia
- CXR
- Cases of stibine
- Add type and cross, and coagulation factors as transfusions are likely required
- Serum level 0.8 - 3 μg/L (6.6-24.6 nmol/L)
- Urine level (24 hr) 0.5-6.2 μg/L (4.1-50.1 nmol/L)
Management
- Consult Toxicology or poison control
- Decontamination
- Gastric lavage may be of benefit
- Activated charcoal
- Additionally may use multi-dose activated charcoal due to enterohepatic circulation
- Dermal exposure
- Irrigation with soap and water
- Supportive Care
- Fluid resuscitation
- Electrolyte repletion
- Monitor I/Os
- Antiemetics
- Blood transfusions based on institutional criteria
- Chelation
- Dimercaprol
- 200-600mg/d IM shown in a case series to increase urinary excretion of antimony1
- Succimer
- Dimercaptopropane-sulfonic acid (DMPS)
- All have shown improved survival in animal models
- Dimercaprol
Stibine
- Place on high flow oxygen
- Consider need for exchange transfusion to remove stibine-hemoglobin complexes
Disposition
- Will require admission to a monitored bed, likely ICU.
References
Tarabar, A. Antimony. In: Goldfrank's Toxicologic Emergencies. 9th Ed. New York: McGraw-Hill; 2011: 1207-1213
- 1. Lauwers LF, Roelants A, Rosseel PM, et al. Oral antimony intoxications in man. Crit Care Med. 1990;18:324-326.